Emerson Electric (EMR) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
5 May, 2026Executive summary
Q2 2026 underlying orders grew 5%, led by Software & Systems and strong demand in North America and India, despite a 1 point impact from the Middle East conflict.
Underlying sales growth was 0.5%, below expectations, while net sales rose 3% to $4.56B; adjusted EPS increased 4% to $1.54, near the top end of guidance.
Adjusted segment EBITDA/EBITA margin reached 27.6%, exceeding expectations; annual contract value (ACV) of software grew 9% year-over-year to $1.64B.
Growth verticals, including power, LNG, life sciences, and aerospace, were up 22% year-over-year, with a project funnel growing to $11.2B.
Management expects a strong second half of fiscal 2026, supported by robust backlog and orders momentum.
Financial highlights
Q2 net sales were $4.56B (+3% YoY); adjusted segment EBITA margin was 27.6%, with price contributing 3.5 points to growth.
Backlog ended at $8.2B, up 9% year-over-year; book-to-bill ratio was 1.07.
Adjusted EPS grew 4% year-over-year to $1.54; Q2 cash flow was $694M with a 15% margin.
GAAP net earnings attributable to common stockholders were $618M, up 27% year-over-year.
Operating cash flow for Q2 was $779M, down 6% year-over-year; free cash flow was $694M.
Outlook and guidance
Full-year 2026 net sales growth expected at ~4.5%, with underlying growth of ~3% and a 1.5% FX tailwind.
Adjusted segment EBITDA/EBITA margin expected at ~28%; adjusted EPS guidance raised to $6.45–$6.55.
Q3 2026 adjusted EPS expected at $1.65–$1.70; free cash flow for the year expected at $3.5–$3.6B.
Capital return plan includes ~$2.2B to shareholders via ~$1B share repurchases and ~$1.2B dividends.
U.S. outlook raised to high single digits; China outlook lowered to mid-single-digit decline.
Latest events from Emerson Electric
- Q1 2026 delivered 4% sales growth, 6% EPS growth, and raised guidance on strong automation demand.EMR
Q1 202617 Apr 2026 - Order growth, AI-driven automation, and software rebound underpin strong long-term outlook.EMR
JPMorgan Industrials Conference 202617 Mar 2026 - AI-driven software growth and robust U.S. demand fuel strong performance and future outlook.EMR
Citi's Global Industrial Tech & Mobility Conference 202618 Feb 2026 - Strong order growth, innovation, and high margins drive a positive outlook and investor confidence.EMR
Barclays 43rd Annual Industrial Select Conference17 Feb 2026 - Targeting $21B sales, 30% EBITA margin, $8.00 EPS, and $10B shareholder returns by 2028.EMR
Investor Update3 Feb 2026 - Director elections and key proposals passed; board declassification did not meet approval threshold.EMR
AGM 20263 Feb 2026 - Q3 sales and adjusted EPS up 11%, Copeland exit boosts debt reduction and guidance raised.EMR
Q3 20242 Feb 2026 - Record FY24 growth, portfolio actions, and $2B buyback set up strong 2025 outlook.EMR
Q4 202416 Jan 2026 - Record margins, 13% EPS growth, and robust cash flow with AspenTech deal pending.EMR
Q1 20259 Jan 2026